Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

BMS-936558 shows promise in RCC and mCRPC in phase I trial

Feb. 25, 2011

AR-42 displays potent antitumor effects in models of embryonal carcinoma

Feb. 25, 2011

Intraprostatic administration of PROSTVAC VF cancer vaccine is feasible and safe

Feb. 24, 2011

Interim phase I data support safety of tremelimumab plus bicalutamide in recurrent prostate cancer

Feb. 24, 2011

PSMA-ADC appears safe in first-in-human study in taxane-refractory metastatic CRPC

Feb. 24, 2011

Gelsolin is a putative biomarker in subarachnoid hemorrhage

Feb. 23, 2011

IST5-002 shows promise in models of prostate cancer

Feb. 23, 2011

Phase I/II trial of panobinostat/bicalutamide combination in prostate cancer advances

Feb. 23, 2011

Tasquinimod improves PFS in phase II trial in metastatic CRPC

Feb. 22, 2011

Promising phase II data on cabozantinib in patients with prostate cancer and soft tissue disease

Feb. 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...